Contact
Please use this form to send email to PR contact of this press release:
Hear from Oxon Epidemiology at Quantitative Benefit – Risk Assessment for the PBRER and Risk Minimisation
TO:
Anna Serazetdinova
SMi Group Ltd
+44 (0) 20 7827 6052